Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
                        
                            
                                申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
                            
                            
                                公开号:EP0531901A2
                            
                            
                                公开(公告)日:1993-03-17
                            
                            
1. A compound of the formula :
 wherein
R¹ isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s),
R² isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), and
Y isa bivalent radical selected from
 (in which ---- means single bond or double bond), each of which may have suitable substituent(s), and
 pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them.
                            1.式中的化合物:
 式中
R¹为芳基,可具有合适的取代基,或为杂环基,可具有合适的取代基、
R² 是芳基,可带有合适的取代基或杂环基,可带有合适的取代基,以及
Y 是二价基,选自
 (其中 ---- 指单键或双键),其中每个基团可具有合适的取代基,以及
 它们的药学上可接受的盐、其制备工艺和包含它们的药物组合物。